nach oben

Tumor Biology

Erschienen in:

06.10.2015 | Original Article

Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines

verfasst von: Rashmi Deshpande, Prakash Mansara, Ruchika Kaul-Ghanekar

Erschienen in: Tumor Biology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Cervical cancer represents the largest cause of mortality in women worldwide. In our previous report, we have shown how alpha-linolenic acid (ALA), an omega-3 fatty acid, regulated the growth of cervical cancer cells. The present study aimed to explore mechanistic details for the anticancer activity of ALA in cervical cancer cell lines, SiHa and HeLa. ALA significantly modulated the growth kinetics of the cells and reduced cell migration with concomitant decrease in the expression of VEGF, MMP-2, and MMP-9 proteins. Besides this, ALA significantly decreased the expression of phosphorylated p38, pERK1/2, c-JUN, NFκB, and COX2, proteins. Most importantly, ALA reduced the expression of HPV onco-proteins E6 and E7, resulting into restoration of expression of tumor suppressor proteins, p53 and Rb. These results suggested that ALA could be explored for its therapeutic potential in cervical cancer.

Nur mit Berechtigung zugänglich

Bruni L. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World Summary Report 2014.

Jing K, Shin S, Jeong S, Kim S, Song KS, Park JH, Heo JY, Seo KS, Park SK, Kweon GR, Wu T, Park JI, Lim K. Docosahexaenoic acid induces the degradation of HPV E6 / E7 oncoproteins by activating the ubiquitin–proteasome system. Cell Death Dis; 2014:1–11.

Shillitoe EJ. Papillomaviruses as targets for cancer gene therapy. Cancer Gene Ther. 2006;13:445–50.CrossRefPubMed

Yeung CLA, Tsang TY, Yau PL, Kwok TT. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53 / microRNA-23b / urokinase-type plasminogen activator pathway. Oncogene;2011: 1–10.

Nevins JR. The Rb/E2F pathway and cancer. Hum Mol Genet. 2001;10:699–703.CrossRefPubMed

Sinha R, De A, Greenwald P. Cancer risk and diet in India. J Postgrad Med. 2003;49:222–8.PubMed

García-Closas R, Castellsagué X, Bosch X, González CA. The role of diet and nutrition in cervical carcinogenesis. A Rev Recent Ev Int J Cancer. 2005;117(4):629–37.

Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S. Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res. 2010;49:76–86.CrossRefPubMed

Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammationand cancer. Expert Opin Ther Targets. 2006;10(1):87–118.CrossRefPubMed

10.

Mansara PP, Deshpande RA, Vaidya MM, Kaul-Ghanekar R. Differential ratios of omega fatty acids (AA/EPA + DHA) modulate growth, lipid peroxidation and expression of tumor regulatory MARBPs in breast cancer cell lines MCF7 and MDA-MB-231. PLoS ONE. 2015;10(9), e0136542.CrossRefPubMedPubMedCentral

11.

Mansara PP, Ketkar M, Deshpande R, Chaudhary A, Shinde K, Kaul-Ghanekar R. Omega-3 fatty acid supplementation in breast cancer patients undergoing chemotherapy improved their antioxidant status—a case series. J Med Case Reports. 2015;9:148.CrossRef

12.

Stark AH, Crawford MA, Reifen R. Update on alpha-linolenic acid. Nutr Rev. 2008;66:326–32.CrossRefPubMed

13.

Burdge GC, Calder PC. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005;45:581–97.CrossRefPubMed

14.

Kim JY, Park HD, Park E, Chon JW, Park YK. Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Ann N Y Acad Sci. 2009;1171:190–5.CrossRefPubMed

15.

Chamberland JP, Moon HS. Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells. Familial Cancer. 2015;14:25–30.CrossRefPubMed

16.

Moon HS, Batirel S, Mantzoros CS. Alpha linolenic acid and oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells. Metabolism. 2014;63:1447–54.CrossRefPubMed

17.

Horia E, Watkins BA. Comparison of stearidonic acid and a-linolenic acid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J Nutr Biochem. 2005;16:184–92.CrossRefPubMed

18.

Deshpande R, Mansara P, Suryavanshi S, Kaul-Ghanekar R. Alpha-linolenic acid regulates the growth of breast and cervical cancer cell lines through regulation of NO release and induction of lipid peroxidation. J Mol Biol. 2013;2:6–17.

19.

Wani KD, Kadu BS, Mansara P, Gupta P, Deore AV, Chikate RC, et al. Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF Nps) for hyperthermia and drug delivery applications in breast cancer. PLoS One. 2014;9:107315.CrossRef

20.

Gebäck T, Schulz MM, Koumoutsakos P, Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques. 2009;46:265–74.PubMed

21.

Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S. Aqueous Cinnamon Extract (ACE- c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential, BMC Cancer; 2010.

22.

Morandell D, Kaiser A, Herold S, Rostek U, Lechner S, Mitterberger MC, et al. The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc- finger protein-1. Virology. 2012;422:242–53.CrossRefPubMedPubMedCentral

23.

Domenico FD, Foppoli C, Coccia R, Perluigi M. Antioxidants in cervical cancer: chemopreventive and chemotherapeutic effects of polyphenols. Biochim Biophys Acta (BBA) - Mol Basis Dis. 1822;2012:737–47.

24.

Hagemann T, Bozanovic T, Hooper S, Ljubic A, Slettenaar VI, Wilson JL, et al. Molecular profiling of cervical cancer progression. Br J Cancer. 2007;96(2):321–8.CrossRefPubMedPubMedCentral

25.

Ueda M, Terai Y, Yamashita Y, Kumagai K, Ueki K, Yamaguchi H, et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer. 2002;321:335–43.CrossRef

26.

Behren A, Simon C, Schwab RM, et al. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase / activator protein-1 signaling pathway kinase / activator protein-1 signaling pathway. Cancer Res. 2005;65:11613–21.CrossRefPubMed

27.

Huang AC, Hsu SC, Kuo CL, Liao CL, Lai KC, Lin TP, et al. Involvement of matrix metalloproteinases in the inhibition of cell invasion and migration through the inhibition of NF- κ B by the New synthesized ethyl 2-[N-p-chlorobenzyl-(2’-(JOTO1007) in human cervical cancer Ca Ski cells. In Vivo. 2009;620:613–9.

28.

Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010;112:3–25.CrossRefPubMed

29.

Choudhari AS, Suryavanshi S, Kaul-Ghanekar R. The aqueous extract of Ficus religiosa induces cell cycle arrest in human cervical cancer cell lines SiHa (HPV-16 Positive) and apoptosis in HeLa (HPV-18 positive). PLoS One. 2013;8:e70127.CrossRefPubMedPubMedCentral

30.

Shen L, Shui Y, Wang X, Sheng L, Yang Z, Xue D, et al. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy. BMC Cancer. 2008;8:232.CrossRefPubMedPubMedCentral

31.

Menéndez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the “fat features” of the “Mediterranean diet” as an “anti-HER2 cocktail”. Clin Transl Oncol. 2006;8(11):812–20.CrossRefPubMed

32.

Mason JK, Klaire S, Kharotia S, Wiggins AK. Thompson LU.α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways. Lipids Health Dis. 2015;14(1):91.CrossRefPubMedPubMedCentral

33.

Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor / coactivator exchange of a corepressor / coactivator exchange. Cancer Res. 2007;15:3976–85.CrossRef

34.

James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-κ B, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner human papillomavirus type 16 E6 activates NF-B, induces cIAP-2 expression, and protects against Apo. J Virol. 2006;80:5301–7.CrossRefPubMedPubMedCentral

35.

Kim S, Oh J, No J, Bang J, Juhnn Y, Song Y. Involvement of NF- k B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. Carcinogenesis. 2009;30:753–7.CrossRefPubMed

36.

Gagnon V, Parent S, Asselin E. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB/IκB pathway. Mol Cancer. 2004;11:1–11.

37.

Chaturvedi MM, Sung B, Yadav V R, Kannappan R, and Aggarwal BB. NF- κB addiction and its role in cancer:one size does not fit all.Oncogene;2010:1–16

38.

Kim SH, Juhnn YS, Kang S, Park SW, Sung MW, Bang YJ, et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK / ERK1, 2 and PI3K / Akt. Cell Mol Life Sci. 2006;63:930–8.CrossRefPubMed

39.

Branca M, Ciotti M, Santini D, Di Bonito L. Activation of the ERK / MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Am J Clin Pathol. 2004;122:902–11.CrossRefPubMed

40.

Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291–310.CrossRefPubMed

41.

Olson JM, Hallahan AR. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med. 2004;10:125–9.CrossRefPubMed

42.

Mason JK, Fu MH, Chen J, Yu Z, Thompson LU. Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474). Nutr Cancer. 2013;65(3):451–9.CrossRefPubMed

43.

Weiss C, Bohmann D. Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle. 2004;3:111–3.CrossRefPubMed

44.

Yamaguchi K, Lantowski A, Dannenberg AJ, Subbaramaiah K. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem. 2005;280:32569–77.CrossRefPubMed

45.

Tan S, De Vries EG, van der Zee AG, de Jong S. Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer. Curr Cancer Drug Targets. 2012;12:170–84.CrossRefPubMed

46.

Chinnam M, Goodrich D. RB1 development, and cancer. Curr Top Dev Biol. 2011;94:129–69.CrossRefPubMedPubMedCentral

47.

Stanley MA, Pett MR, Coleman N. HPV : from infection to cancer. Biochem Soc Trans. 2007;35(6):1456–60.CrossRefPubMed

48.

Das UN, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Essent Fat Acids. 1998;58:39–54.CrossRef

49.

Sangeetha P, Das UN, Koratkar R, Ramesh G, Padma M. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells: relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett. 1992;63:189–98.CrossRef

50.

Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002;61:345–58.CrossRefPubMed

51.

Calder PC. Long-chain polyunsaturated fatty acids and inflammation. Scan J Food Nut. 2006;50:5461.

52.

Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutr Cancer. 2008;60(3):331–41.CrossRefPubMed

Titel: Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines
verfasst von: Rashmi Deshpande
Prakash Mansara
Ruchika Kaul-Ghanekar
Publikationsdatum: 06.10.2015
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 3/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-4170-z

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism

Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma

MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor

Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis

CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma

Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie